Those taking amycretin lost almost a quarter of their body weight in 36 weeks, the best result yet for a GLP drug

Those taking amycretin lost almost a quarter of their body weight in 36 weeks, the best result yet for a GLP drug

Participants in trial of amycretin injectable obesity drug lost an average of 24% of their body weight on highest dose